American Century Companies
ALXO icon

American Century Companies’s ALX Oncology ALXO Stock Holding History

American Century Companies’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-23,685
Closed -$143K – 2883
2024
Q2 		$143K Sell
23,685
-5,978
-20% -$73.5K ﹤0.01% 2781
2024
Q1 		$331K Buy
29,663
+8,467
+40% +$119K ﹤0.01% 2605
2023
Q4 		$316K Buy
21,196
+10,939
+107% +$104K ﹤0.01% 2542
2023
Q3 		$49.2K Buy
+10,257
New +$55.7K ﹤0.01% 2807

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies's ALXO Position: Q3 2024 in Review

American Century Companies sold out of ALX Oncology (ALXO) in Q3 2024, closing a stake of 23,685 shares — an estimated $143K sold.

American Century Companies first reported a position in ALXO in Q3 2023 and held it in 4 quarters. The position peaked at $331K in Q1 2024. 92 funds tracked by Wall St. Rank hold ALXO as of Q3 2024.

  • American Century Companies reported no remaining ALX Oncology position as of Q3 2024 after selling out during the quarter.
  • American Century Companies sold 23,685 ALX Oncology shares in Q3 2024, an estimated $143K.
  • American Century Companies first reported a position in ALX Oncology in Q3 2023 and held it in 4 quarters.
  • American Century Companies's ALX Oncology position peaked at $331K in Q1 2024.
  • 92 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2024.

Based on American Century Companies's 13F filing for Q3 2024, filed 12 Nov 2024.